SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (3603)10/23/2018 6:03:29 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3661
 
Thanks, I see my mistake with *5*---> *4*.

I did not have preclinical data on RO6874281, and I was wrong, but article on CEA-IL2v show binding to beta/gama, ncbi.nlm.nih.gov

Your point of 'big" antibody not capable to penetrate cancer environment is well-taken. But, than again need to split FAP part to generate active IL-2v part, or I am again wrong here???